CF
ARKG icon

Centaurus Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Centaurus Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,169
Closed -$177K – 798
2024
Q1 		$177K Sell
6,169
-334
-5% -$10K 0.01% 645
2023
Q4 		$213K Sell
6,503
-6
-0.1% -$163 0.02% 576
2023
Q3 		$181K Buy
6,509
+20
+0.3% +$654 0.02% 590
2023
Q2 		$221K Sell
6,489
-3,456
-35% -$109K 0.02% 545
2023
Q1 		$299K Buy
9,945
+1,209
+14% +$37.5K 0.02% 541
2022
Q4 		$247K Buy
8,736
+247
+3% +$7.84K 0.02% 552
2022
Q3 		$279K Buy
8,489
+339
+4% +$12.4K 0.03% 510
2022
Q2 		$257K Sell
8,150
-20
-0.2% -$699 0.03% 532
2022
Q1 		$375K Sell
8,170
-177
-2% -$8.44K 0.03% 488
2021
Q4 		$511K Buy
8,347
+242
+3% +$16.7K 0.04% 430
2021
Q3 		$606K Sell
8,105
-31,108
-79% -$2.61M 0.05% 374
2021
Q2 		$3.63M Buy
39,213
+31,577
+414% +$2.68M 0.31% 79
2021
Q1 		$678K Buy
7,636
+1,096
+17% +$109K 0.07% 304
2020
Q4 		$610K Buy
6,540
+857
+15% +$68.3K 0.06% 324
2020
Q3 		$362K Buy
5,683
+3,458
+155% +$203K 0.05% 328
2020
Q2 		$116K Buy
+2,225
New +$95.4K 0.02% 557
2018
Q3 		– Sell
-120
Closed -$3K – 613
2018
Q2 		$3K Buy
+120
New +$3.34K ﹤0.01% 1907

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Centaurus Financial's ARKG Position: Q2 2024 in Review

Centaurus Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 6,169 shares — an estimated $177K sold.

Centaurus Financial first reported a position in ARKG in Q2 2018 and held it in 17 quarters. The position peaked at $3.63M in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Centaurus Financial reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Centaurus Financial sold 6,169 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $177K.
  • Centaurus Financial first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 17 quarters.
  • Centaurus Financial's ARK Genomic Revolution ETF position peaked at $3.63M in Q2 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Centaurus Financial's 13F filing for Q2 2024, filed 23 Sep 2024.